Autism
NEWS RELEASE
Released: January 14, 2021
Defense Health Program
Department of Defense Autism Research Program
Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)
Although the FY21 Defense Appropriations Bill has been signed into law, the FY21 appropriation for the Department of Defense Autism Research Program (ARP) is contingent upon the outcome of a pending rescissions request. The ARP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY21 funding opportunities. This pre-announcement should not be construed as an obligation by the Government.
The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense ARP to support research of exceptional scientific merit and innovation with high impact that focuses on autism spectrum disorders (ASD). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate, manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
Subject to the FY21 Congressional appropriation for ARP funding, FY21 ARP Program Announcements and General Application Instructions for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the Program Announcements are released.
Award Mechanism | Eligibility | Key Mechanism Elements | Funding |
---|---|---|---|
Clinical Trial Award | Investigators at or above the level of Assistant Professor (or equivalent) or
Nested Early-Career Investigator Option: Investigators at or above the level of Assistant Professor (or equivalent) may collaborate on a single application with a young investigator (at the level of postdoctoral fellow up to early-career independent faculty) who meets the following criteria at the application submission deadline date:
|
|
Nested Early-Career Investigator Option:
|
Clinical Translational Research Award | Investigators at or above the level of Assistant Professor (or equivalent). |
|
|
Idea Development Award | Investigators at or above the level of Assistant Professor (or equivalent).
Multiple PI Option:
|
|
|
Career Development Award |
Independent investigators at or below the level of Assistant Professor (or equivalent) or
Established independent investigators in an area other than ASD at or above the level of Assistant Professor (or equivalent) and seeking to transition to a career in ASD, thereby bringing their expertise to the field. Investigators must not have received a Career Development Award (or equivalent) previously from any program within the CDMRP. Investigators must not have received more than $300,000 in total direct costs for previous or concurrent ASD research as a Principal Investigator of one or more federally or privately funded, non-mentored, peer-reviewed grants. |
|
|
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the ARP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.health.mil).
Point of Contact:
CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil
Last updated Thursday, December 5, 2024